The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $53.49

Today's change0.00 0.00%
Updated May 2 4:03 PM EDT. Delayed by at least 15 minutes.
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $53.49

Today's change0.00 0.00%
Updated May 2 4:03 PM EDT. Delayed by at least 15 minutes.

Teva Pharmaceutical Industries Ltd closed at (U.S.)$53.49.

Over the last five days, shares have lost 4.09% and sit 1.65% above their 52-week low. This security has underperformed the S&P 500 by 12.69% during the last year.

Key company metrics

  • Open(U.S.) $53.98
  • Previous close(U.S.) $53.49
  • High(U.S.) $54.07
  • Low(U.S.) $53.31
  • Bid / Ask-- / --
  • YTD % change-18.51%
  • Volume11,269,956
  • Average volume (10-day)6,580,251
  • Average volume (1-month)5,705,856
  • Average volume (3-month)5,474,260
  • 52-week range(U.S.) $52.62 to (U.S.) $72.31
  • Beta0.81
  • Trailing P/E29.37×
  • P/E 1 year forward10.14×
  • Forward PEG1.50×
  • Indicated annual dividend(U.S.) $1.36
  • Dividend yield2.54%
  • Trailing EPS(U.S.) $1.82
Updated May 2 4:03 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue4,8814,8234,9664,982
Total other revenue--------
Total revenue4,8814,8234,9664,982
Gross profit2,8472,7712,9022,836
Total cost of revenue2,0342,0522,0642,146
Total operating expense3,9503,8134,3044,233
Selling / general / administrative1,2071,0891,1771,221
Research & development446361386332
Depreciation / amortization--788
Interest expense (income), net operating--------
Unusual expense (income)263304669526
Other operating expenses, total--------
Operating income9311,010662749
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax861313621557
Income after tax612120533453
Income tax, total24919388104
Net income500103539446
Total adjustments to net income-15------
Net income before extra. items500103539446
Minority interest2-1302
Equity in affiliates-114-46-9
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items485103539446
Inc. avail. to common incl. extra. items485103539446
Diluted net income485103539447
Dilution adjustment0001
Diluted weighted average shares876862859859
Diluted EPS excluding extraordinary itemsvalue per share0.550.120.630.52
Dividends per sharevalue per share0.340.340.340.34
Diluted normalized EPSvalue per share0.770.351.301.02